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Abstract
Type 3 secretion systems (T3SSs) of bacterial pathogens translocate bacterial effector proteins that 
mediate disease into the eukaryotic cytosol. Effectors traverse the plasma membrane through a 
translocon pore formed by T3SS proteins. In a genome-wide selection, we identified the 
intermediate filament vimentin as required for infection by the T3SS-dependent pathogen Shigella 
flexneri. We found that vimentin is required for efficient T3SS translocation of effectors by S. 
flexneri and other pathogens that use T3SS, Salmonella Typhimurium and Yersinia 
pseudotuberculosis. Vimentin and the intestinal epithelial intermediate filament keratin 18 interact 
with the C-terminus of the Shigella translocon pore protein IpaC. Vimentin and its interaction with 
IpaC are dispensable for pore formation, but are required for stable docking of S. flexneri to cells; 
moreover, stable docking triggers effector secretion. These findings establish that stable docking of 
the bacterium specifically requires intermediate filaments, is a process distinct from pore 
formation, and is a prerequisite for effector secretion.
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T3SSs are highly conserved structures used by >30 bacterial pathogens of humans, animals, 
and plants to establish infection through the delivery of effector proteins into host cells1, 2. 
T3SSs comprise a base that spans the bacterial membranes, a hollow needle that is anchored 
in the base and extends away from the bacterial surface, and a cap that prevents non-specific 
secretion1, 3, 4. Delivery of effectors into the host cytosol is tightly controlled5, 6. Contact of 
the cap with the plasma membrane activates the T3SS to secrete two proteins that form the 
translocon pore6, 7, which is required for delivery of effectors into the host cytosol. The 
timing of the delivery of effectors is likely regulated by signaling through the T3SS during 
interaction with the host. Loss of either cap protein, IpaD or IpaB, causes constitutive 
secretion5, and certain mutations of the needle8 or translocon proteins9, 10 alter the rate or 
selection of substrates secreted through the T3SS. A sorting platform that integrates these 
signals at the cytoplasmic membrane was identified in Salmonella enterica 
serovarTyphimurium11, 12; this platform is predicted to interact with bacterial effectors and 
their chaperones to coordinate loading of effectors into the T3SS. It is proposed that 
translocation of effectors into the host cell depends on docking of the T3SS needle on the 
translocon pore13, 14, which would allow passage of effectors from the bacterial cytosol to 
the host cytosol in a single step. Yet, whether docking occurs and which mechanisms 
regulate it are uncertain.
In a genome-wide selection designed to discover host factors involved in the pathogenesis of 
S. flexneri, we identified the intermediate filament vimentin. We demonstrate that 
intermediate filaments interact with the Shigella translocon pore protein IpaC. Vimentin and 
its interaction with IpaC are required for stable docking of S. flexneri on cells and for 
efficient translocation of T3SS effectors into cells, but not for T3SS translocon pore 
formation, indicating that stable docking of bacteria is a process that is distinct from pore 
formation. Moreover, docked bacteria, but not undocked bacteria, actively secrete effectors. 
These data establish that docking of the bacterium on the cell is required for efficient 
secretion and translocation of T3SS effector proteins.
Results
Host intermediate filaments are required for efficient S. flexneri infection
S. flexneri invasion of colonic enterocytes, which requires T3SS-mediated translocation of 
effector proteins into the host cytosol15, 16, is promoted by several functionally-independent 
host proteins17-21. To identify additional host genes required for S. flexneri infection, we 
performed a genome-scale selection in a loss-of-function library of human-derived haploid 
(Hap-1) cells22, 23. Selection of cells in the library was optimized by serial infection with S. 
flexneri that produced the E. coli adhesin Afa-124, which binds to CD55, a GPI-anchored 
human cell surface receptor. The adhesin enhanced S. flexneri attachment to Hap-1 cells and 
reduced Hap-1 survival from 20% to 5% (Fig. S1a). This approach, in conjunction with 
serial infections, enabled a highly stringent selection, with <0.1% Hap-1 cell survival (Fig. 
S1b). Hap-1 cell killing was dependent on S. flexneri invasion; infection with an invasion-
deficient strain caused minimal cell death (Fig. S1a). S. flexneri infection lead to enrichment 
of 81 host genes (p value <0.05, Table S1), determined by sequencing of loss-of-function 
mutation sites within genomes of selected cells versus unselected cells. The most highly 
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enriched genes included CD55 and genes associated with its biosynthesis, demonstrating 
specificity for the strain used in the selection. Among other genes that were enriched was 
ARF6, which encodes a small GTPase involved in endocytosis that we have since shown is 
required for efficient S. flexneri invasion21, further validating the selection.
Multiple host pathways contribute to S. flexneri infection, which raised the possibility that 
the relatively low level of enrichment of genes in the selection might be due at least in part 
to host redundancy. To prioritize the output, we screened for host pathways that contained 
more than one of the top 81 genes enriched by selection. A single multi-gene cluster was 
identified that included the enriched gene encoding the intermediate filament vimentin. 
Vimentin interacts directly with the enriched gene PKP1 (plakophilin I) and indirectly with 
the enriched genes PRKRIR (repressor of the inhibitor of serine/threonine protein kinase R), 
MID1 (midline-1), and NOL3 (nucleolar protein 3) (Fig. S1c). Intermediate filaments 
participate in a wide variety of cellular functions, including cell migration, signal 
transduction, and immune responses25-27. However, they are the least studied of the three 
major cellular cytoskeletal components, and their role during bacterial infection is poorly 
characterized. Since multiple enriched genes clustered with vimentin, and intermediate 
filament function in bacterial pathogenesis was poorly understood, vimentin was selected for 
further study.
Infection with S. flexneri lacking the Afa-1 adhesin caused 5.5-fold more cell death for 
mouse embryonic fibroblasts (MEFs) expressing vimentin (Vim+/+) than for MEFs lacking 
vimentin (Vim−/−) (Fig. 1a), confirming the results of the Hap-1 screen and indicating that 
vimentin was required for S. flexneri-induced cell death independently of the adhesin. 
Vimentin is the only cytosolic intermediate filament produced in these MEFs28, and cell 
death was partially rescued by expression of human vimentin in Vim−/− MEFs (Fig. 1a-b), 
indicating that cell death in the Vim+/+ cells was due to the presence of vimentin and that 
human vimentin functions in S. flexneri infection.
Intermediate filaments are required for efficient translocation by T3SSs
Intermediate filaments were required for effector protein translocation. Compared to Vim+/+ 
cells, the efficiency of translocation by S. flexneri into Vim−/− cells was reduced 62% ± 9% 
(Fig. 1c-d), as determined by cleavage of β-lactamase in cells loaded with the β-lactamase 
sensitive reporter CCF4-AM and infected with bacteria that deliver the T3SS effector OspB 
fused to β-lactamase. Similarly, efficient translocation of FLAG-tagged OspB, detected by 
differential fractionation of the cellular cytosol, depended on vimentin (Fig. S2).
The requirement for intermediate filaments to deliver T3SS effector proteins was conserved 
among other bacterial pathogens. Compared to Vim+/+ cells, translocation into Vim−/− cells 
was reduced by 94% ± 3% and 55% ± 7% for Salmonella Typhimurium (Fig. 1e) and 
Yersinia pseudotuberculosis (Fig. 1f), respectively. These results suggest that bacterial T3SS 
may generally require intermediate filaments to translocate effector proteins.
As might be expected from the observed defect in effector translocation, S. flexneri invasion 
was also defective in the absence of intermediate filaments (Fig. S3). The defect in effector 
translocation into Vim−/− MEFs correlated directly with defects in bacterial invasion (Fig. 
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S3a-c). Natural infection by Shigella spp. occurs in the human colonic epithelium, in which 
keratins 8, 18, and 19 are expressed in the epithelial cells and vimentin is expressed in M 
cells and macrophages29, 30. Similar defects in invasion were observed in polarized human-
derived Caco2 intestinal epithelial cells lacking keratin 8 or keratin 18 (Fig. S3d-e). Thus, 
for mammalian cell types relevant to natural infection, intermediate filaments were 
associated with events downstream of translocation, i.e., invasion of S. flexneri into cells.
The effect of vimentin on S. flexneri infection was independent of a general impact on the 
host cytoskeleton. Infection did not cause detectable rearrangements of intermediate 
filaments (Fig. S4). Moreover, although fewer actin-enriched entry sites were observed in 
Vim−/− cells compared to Vim+/+ cells (Fig. S5), among the subset of each that were 
infected, S. flexneri recruited actin to entry sites (Fig. S5b), indicating that actin 
rearrangements per se occur independently of vimentin.
T3SS translocon pore proteins interact with intermediate filaments
Intermediate filaments participate in functional interactions with the cortical actomyosin 
cytoskeleton31 and are also detected on the surface of cells32, 33. IpaC and its homologs are 
predicted to insert with the N-terminus extracellular and to contain either one or two 
hydrophobic transmembrane segments, placing the C-terminus either in the host cytosol or 
on the cell surface, respectively34-36 (Fig. S6a). The S. Typhimurium translocon pore protein 
SipC interacts with keratins in vitro37, 38, which raised the possibility that T3SS translocon 
proteins may interact with the intermediate filament cytoskeleton during infection. Human 
vimentin and keratins share substantial structural similarity26 and 30-36% amino acid 
sequence similarity. Using a distinct yeast-based cytoplasmic protein-protein interaction 
assay39, IpaC interacted specifically with vimentin (Fig. 2a). IpaC also interacted 
specifically with the intestinal intermediate filament keratin 18, but not with keratin 8 (Fig. 
2b), suggesting that in the intestine, IpaC might interact with the keratin 18 component of 
the keratin 8-keratin 18 heterodimer. SipC, the S. Typhimurium homolog of IpaC, interacted 
with keratin 8 and keratin 18, consistent with previous reports37, 38, and interacted weakly 
with vimentin (Fig. 2c). YopD, the Y. pseudotuberculosis homolog of IpaC and SipC, 
interacted with vimentin and keratin 8 (Fig. 2d). Thus, like IpaC, homologs in two other 
enteric pathogens interact with intermediate filament proteins, indicating the interaction of 
the translocon pores with intermediate filaments is conserved among T3SSs.
The penultimate C-terminal residue of IpaC, R362, is conserved in S. Typhimurium (Fig. 
S6b) and required for S. flexneri invasion34, 35, 40. IpaC R362 was required for IpaC binding 
to intermediate filaments, as mutation to glutamine, leucine, or tryptophan markedly reduced 
IpaC interactions with vimentin or keratin 18, while not altering the level of protein 
synthesis, as determined by the intensity of the fluorescent signal from the IpaC construct 
(Fig. 2e-f and S7). Although YopD does not contain a residue homologous to IpaC R362, 
IpaC S349 is conserved across the three translocon homologs (Fig. S6b) and was required 
for interaction of IpaC with vimentin or keratin 18 (Fig. 2e-f). IpaC forms a hetero-
oligomeric pore with IpaB7, yet co-expression of IpaB neither strengthened the interaction 
of IpaC with vimentin, nor rescued the interactions between the IpaC R362 mutants and 
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vimentin (Fig. S8), suggesting that the interaction of IpaC with intermediate filaments is 
independent of IpaB.
The interaction of intermediate filaments with the translocon pore was required for efficient 
translocation. For S. flexneri producing IpaC mutants R362E, R362L, R362W, and S349A, 
the mutants showing reduced interaction with intermediate filaments, translocation 
efficiency was reduced by 73-90% compared to that of S. flexneri producing WT IpaC (Fig 
2g). The translocation defect for IpaC R362W was also observed for translocation of OspB-
FLAG into HeLa cells (Fig. S9), a common Shigella cell-based model that expresses 
vimentin, keratin 8, and keratin 18 (Fig. S4). It seemed unlikely that the defect in 
translocation efficiency of the IpaC mutants was due to a non-specific effect of the mutations 
on IpaC, as other functions of IpaC were normal, including secretion through the T3SS (Fig. 
S10a-b), as determined by chemical activation of T3SS activity with Congo red, and pore 
formation (Fig. S10c-d), as determined by hemoglobin release upon lysis of sheep 
erythrocytes resulting from translocon pore formation in the erythrocyte membrane7. 
Further, the C-terminus of IpaC polymerizes actin, yet mutation of R362 does not alter actin 
polymerization activity40. Thus, efficient translocation by T3SSs depends on the interaction 
of the C-terminal domain of IpaC with intermediate filaments.
Translocon pores form independently of intermediate filaments in nucleated cells
Sheep erythrocytes lack intermediate filaments, but Shigella forms pores in these cells (Fig. 
S10), which indicates that pore formation per se occurs in the absence of intermediate 
filaments. Supporting this, the abundance of IpaB and IpaC in the membranes of Vim−/− and 
Vim+/+ MEFs was similar (Fig. 3a).
As the efficiency of pore formation and pore diameter impact bacterial effector translocation 
into the cytosol41, we tested whether the presence of intermediate filaments contributed to 
these traits. Unlike erythrocytes, in mammalian cells that normally contain intermediate 
filaments, pores formed by many T3SSs are not detected by lysis or dye release, presumably 
because they are blocked by the presence of effector proteins, since removal of effectors 
from Y. pseudotuberculosis enabled detection of pores41, 42. As cells naturally infected by 
Shigella contain intermediate filaments, we developed a system for analysis of translocon 
pore formation in these cells. As previously for WT Y. pseudotuberculosis43, pores were not 
detectable in cells infected with WT S. flexneri, which produces ~30 T3SS effectors, as 
minimal release of the small molecule dye BCECF (2’,7’-bis-(2-carboxyethyl)-5 (and 6)-
carboxyfluorescein) was observed (Fig. S11). Of note, release of BCECF upon infection 
with WT S. flexneri was similar for Vim+/+ and Vim−/− macrophages (Fig. S12), suggesting 
that basal levels of translocation observed in Vim−/− cells (Fig. 1d) may be sufficient to 
block dye release or that other mechanisms contribute to blockage of pores formed by S. 
flexneri.
In contrast, E. coli pSfT3SS44, which is analogous to the effector-less Y. pseudotuberculosis 
system in that it carries the T3SS apparatus of S. flexneri and only 4 of the S. flexneri 
effectors, formed pores that were detectable by BCECF release (Fig. 3b-d). As for WT S. 
flexneri, efficient invasion and efficient translocation of the effector reporter OspB-TEM by 
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E. coli pSfT3SS depended on vimentin (Fig. 4a-c), supporting use of this E. coli system as a 
model for the role of vimentin in S. flexneri T3SS function.
The percentage of cells from which dye was released and the kinetics of its release were 
similar for Vim+/+ and Vim−/− cells (Fig. 3b-c), indicating that the efficiency of pore 
formation is independent of vimentin. To test whether vimentin altered the diameter of pores 
that formed, we measured dye release in the presence of osmoprotectants of varying 
diameters, since the diameter of an osmoprotectant that blocks dye release from cells 
corresponds to the diameter of the pores that are formed in the plasma membrane41, 42. Pore 
diameter was similar in E. coli pSfT3SS-infected Vim+/+ and Vim−/− cells, as they each 
required PEG6000 to block infection-induced dye release (Fig. 3d). Moreover, in 
erythrocytes, the diameter of pores formed by E. coli pSfT3SS was similar to that of pores 
formed by WT S. flexneri, albeit their formation was less efficient (Fig. 4d-e).
Although pore formation in macrophage membranes activates the NLRP3 inflammasome45, 
it is unlikely the observed BCECF dye release was solely due to inflammasome activation in 
the ~90 min assays we used, since even at 4 hours of infection, E. coli pSfT3SS does not 
cause LDH release44, an indicator of loss of membrane integrity and cell viability. In 
HEK293T cells, which lack known inflammasome components46, infection with E. coli 
pSfT3SS induces dye release, whereas infection with WT S. flexneri does not (Fig. S11). 
Moreover, efficient activation of inflammasomes requires vimentin47, yet we observed no 
decrease in dye release in Vim−/− cells compared to Vim+/+ cells, further suggesting that the 
observed dye release was not due to inflammasome activation.
These results indicate that, whereas translocation of effectors depends on intermediate 
filaments, translocon pore formation occurs independently of them. Thus, pore formation in 
the plasma membrane is necessary but not sufficient for T3SS effector translocation. 
Moreover, in addition to participating in formation of the translocon pore, IpaC promotes 
bacterial effector translocation in a manner that depends on interactions between it and 
intermediate filaments.
Intermediate filaments are required for efficient S. flexneri docking to cells
To translocate effector proteins into host cells, the T3SS needle complex, which is anchored 
in the bacterial membrane, must either dock onto the translocon pore or secrete effectors 
nearby. For S. Typhimurium, the translocon pore itself is required for efficient docking of 
the bacterium to the host cell13, 14, suggesting that interaction of the needle complex with 
the translocon pore contributes to docking. We tested whether the interaction of IpaC with 
intermediate filaments promotes efficient docking by assessing, in a laminar flow chamber, 
binding of bacteria centrifuged onto cells. Bacterial entry was prevented by treatment of 
cells with cytochalasin D (Fig. S13a). S. flexneri docking to Vim+/+ cells was five-fold more 
efficient than to Vim−/− cells and was dependent on IpaC (Fig. 5a-b). Similar results were 
obtained in the absence of laminar flow (Fig. S13b). S. flexneri docking depended on the 
ability of IpaC to interact with intermediate filaments, as docking to Vim+/+ MEFs by 
bacteria producing WT IpaC was significantly greater than docking of S. flexneri producing 
IpaC R362W (Fig. 5c). Thus, intermediate filaments promote S. flexneri docking in a 
manner that is dependent upon their interaction with IpaC.
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For certain pathogenic E. coli, attachment to host cells is promoted by intermediate 
filaments. Tir, a T3SS effector of enteropathogenic E. coli interacts with keratin 18 in a 
complex with 14-3-3, which increases bacterial attachment at the pedestal48. The E. coli K1 
surface protein IbeA promotes attachment to brain endothelial cells via interactions with 
vimentin33. The nature of these interactions is distinctly different from that described herein, 
in that for S. flexneri, they depend on the T3SS translocon pore.
Effector secretion occurs upon bacterial docking to cells
To determine whether bacterial docking is required for activation of effector secretion, we 
assessed T3SS activity within individual bacteria upon contact with Vim−/− versus Vim+/+ 
MEFs using TSAR (transcription based secretion activity reporter49). The percentage of 
bacteria displaying activation of T3SS was similar for bacteria docked on Vim+/+ MEFs and 
bacteria docked on Vim−/− MEFs (Fig. 6a-b), although as above, substantially more bacteria 
were docked to the Vim+/+ MEFs (Fig. 6a and c). For bacteria that had been brought into 
contact with cells but did not dock, essentially none displayed activation of T3SS (Fig. 6d-
e). Complementation of Vim−/− MEFs with human vimentin restored the number of TSAR 
positive bacteria docked to cells (Fig. 6f), indicating that the absence of vimentin was 
responsible for the defect in docking and that human vimentin functions in this process, 
providing further support for the role of intermediate filaments in S. flexneri docking and 
translocation. These results indicate that stable docking of the bacterium to the cell is 
associated with activation of effector secretion.
Discussion
A critical feature of T3SSs is the hierarchical secretion of substrates through the needle, 
such that the translocon pore proteins are secreted and inserted into the plasma membrane 
before secretion of effector proteins. By ensuring that the translocon pore is in place before 
effectors are secreted, this process guarantees that effector proteins are efficiently 
translocated into the host cytosol. Proper timing of effector secretion is facilitated by a 
sorting platform in the bacterial cytosol at the base of the T3SS apparatus that is loaded in a 
sequential manner with substrates11, 12. Data presented here establish that stable docking of 
S. flexneri on the host cell is independent of translocon pore formation per se, yet is 
dependent on the presence of intermediate filaments in the host cell and on their interaction 
with the translocon pore protein IpaC. Moreover, activation of effector secretion is 
associated with stable docking, but not with formation of the translocon pore.
These data support a model in which the tip of the T3SS transiently interacts with the host 
membrane to insert the translocon pore. We speculate that the interaction of IpaC with 
intermediate filaments, either in the host cytosol or at the cell surface, alters the extracellular 
aspect of the translocon pore complex in a manner that promotes stable docking of the 
needle apparatus (Fig. S14). Whether other proteins that were identified in our selection and 
which interact with vimentin also participate in bacterial docking is currently unknown. Our 
data demonstrate that pore formation and docking can be functionally separated (Fig. 3 and 
5). In the context of infection, it is likely that these steps occur in concert, i.e., that as IpaC is 
inserted into the membrane, it is adjusted by interaction with intermediate filaments in a 
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manner that allows the associated bacterium to stably dock. Consistent with a role of 
docking in the activation of effector secretion is the observation that mutations in MxiH8, the 
needle component of the S. flexneri T3SS, or in IpaD10, 50, 51, the cap protein on the needle 
complex, alter the selection of substrates and the rate of secretion through the T3SS, 
suggesting that these mutations are associated with conformational changes that promote the 
secretion of effectors3, 8, 51. Thus, we speculate that docking, enabled by the interaction of 
IpaC with intermediate filaments, leads to additional conformational changes that trigger 
effector secretion, resulting in effector translocation. These mechanisms are likely to be 
relevant to all the bacterial pathogens that utilize T3SSs during human infection.
Methods
Bacterial strains and plasmids
The strains and plasmids used in this study are listed in Table S2. The wild-type S. flexneri 
strain used in this study is serotype 2a strain 2457T52; all other S. flexneri strains used in 
this study are isogenic to it. BS103 is the virulence plasmid-cured derivative of 2457T53. 
2457T ΔipaC was generated by P1-mediated transduction of the kanamycin-resistant locus 
from serotype 5a strain M90T ΔipaC::km54. E. coli pSfT3SS, which is DH10B carrying a 
portion of the S. flexneri 2457T virulence plasmid, has been described44. Of note, E. coli 
pSfT3SS does not produce IbeA, a protein that binds vimentin33. The sequences of primers 
used in PCR and sequencing are available from the authors upon request.
Cells
Vimentin +/+ (Vim+/+) and vimentin −/− (Vim−/−) mouse embryonic fibroblasts (MEFs) 
were kindly provided by Victor Faundez (Emory), and HeLa cells (ATCC, CCL2) and 
HEK-293T (ATCC, CRL-3216) were obtained from ATCC. These cells were maintained in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 0.45% glucose, 10% 
heat-inactivated fetal bovine serum under humidified air containing 5% CO2 at 37°C. Vim−/− 
MEFs were complemented using a human cDNA encoding vimentin (Thermo Scientific) 
cloned into the pBABE-puro retroviral vector. Retroviral particles packaging the vimentin 
gene or no insert were generated by transfection of 293T cells using pAdvantage (Promega), 
CMV-VSV-G and Gag-Pol, and were used to infect Vim−/− MEFs. Puromycin-resistant 
stable cell populations were generated, and clonal populations were isolated by limiting 
dilution. Knock-down of keratin 8 or keratin 18 in Caco-2 cells was by lentiviral 
transduction of control (sc-108080, Santa Cruz), keratin 8 (sc-35156-V, Santa Cruz), or 
keratin 18 (sc-35151-V, Santa Cruz) shRNA, with selection for puromycin-resistant, stable 
cell populations, performed by the Harvard Digestive Diseases Center. Bone-marrow derived 
macrophages were isolated from the bone marrow of the femurs and tibias of Vim+/+ and 
Vim−/− mice. The macrophages were differentiated from other bone marrow cells for 7 days 
in DMEM supplemented with 20% FBS, 25% L-cell supernatant, 25mM HEPES, 1% 
sodium pyruvate, 1% non-essential amino acids, 0.45% glucose and 1% glutamine55. 
Macrophages were used on days 7-21. All cells in the laboratory are periodically tested for 
mycoplasma; cells that test positive are treated or discarded.
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Genome-wide S. flexneri selection of mutagenized HAP1 cells
A library of mutagenized HAP1 cells was generated as described previously22. Briefly, 
gene-trap retrovirus was produced in HEK-293T cells by transfection of pGT-GFP, pGT-
GFP+1 and pGT-GFP+2 combined with appropriate packaging plasmids. Retrovirus was 
concentrated using ultracentrifugation before infecting 10×106 HAP1 cells in the presence 
of 8 μg/ml protamine sulfate (Sigma).
For selection with S. flexneri, cells were seeded in ten T175 flasks at 1 × 106 cells per flask 
in Iscove's modified Dulbecco's medium (IMDM) supplemented with 10% FBS, 0.45% 
glucose, and GlutaMAX, and were incubated at 37°C with 5% CO2. To achieve optimal 
selection of the Hap-1 cells, three serial infections with S. flexneri harboring pAfa-1, which 
contains a pilus adhesin of uropathogenic E. coli56, were performed. Each infection resulted 
in killing of approximately 95% of cells. Three infections were required to achieve killing of 
greater than 99.9% of cells (Fig. S1).
For each infection, cells were infected at a multiplicity of infection (MOI) of 100 using a 
small volume of media, so as to promote bacteria-cell contact. After 1 hour at 37°C, cells 
were washed 5 times and gentamicin was added to 25 μg/mL. Following incubation for an 
additional 20 hours at 37°C, gentamicin was washed out and two hours later, the next 
infection was carried out. After the third infection, cells were allowed to grow out for seven 
days, until the total number of surviving cells reached approximately 1×108.
Mapping of gene trap insertion sites
Insertion sites were identified as described previously23. Briefly, genomic DNA was isolated 
from 30×106 cells using a QIAamp DNA mini kit (Qiagen). Genomic DNA was digested 
with NlaIII, heat-inactivated and purified with a PCR purification kit (Qiagen). To generate 
the S. flexneri-selected dataset, insertion sites were identified by sequencing the genomic 
DNA flanking gene trap proviral DNA as reported previously23, 57. Deep sequencing was 
performed on an Illumina HiSeq2500 at the Biopolymers Facility at Harvard Medical 
School. The number of inactivating mutations (i.e. sense orientation or present in exon) per 
individual gene was determined, as well as the total number of inactivating insertions for all 
genes. A gene enrichment score was calculated for each gene by comparing the number of 
insertions in a gene per total number of insertions in the experimental dataset versus an 
unselected HAP1 control dataset that has been previously reported23. For each gene a p-
value (corrected for false discovery rate) was calculated using the one-sided Fisher exact 
test, which yielded a total of 81 significantly enriched genes (p<0.05, Table S1). To 
prioritize the list of candidate genes, pathway analysis of these 81 enriched genes was 
performed using g:Profiler58. As a result of pathway analysis (Fig. S1c), 5 of the 81 enriched 
genes were prioritized, and vimentin was chosen for further study due to its poorly described 
role for bacterial infection and its physiological role as a component of the cytoskeleton.
Microscopy-based cell survival assay
Vim+/+ and Vim−/− MEFs, seeded at 4×105 cells per well in a 6-well tissue culture-treated 
plate, were infected with S. flexneri at a multiplicity of infection (MOI) of 100. Bacterial 
entry was synchronized by centrifugation at 800xg for 10 min at 25°C. Infected cells were 
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incubated for 50 min at 37°C with 5% CO2, washed, and incubated in DMEM supplemented 
with 10% FBS and 50 μg/mL of gentamicin, which specifically kills the extracellular 
bacteria, for 23 hours at 37°C with 5% CO2. Cell viability was assessed by phase 
microscopy, and the number of viable cells was quantified by trypan staining and 
trypsinization of adherent cells, with enumeration using a hemocytometer.
Differential fluorescent microscopy
Differential staining to distinguish intracellular versus extracellular bacteria was performed 
as described previously21. Vim+/+ and Vim−/− MEFs were seeded at 3×105 cells per well in a 
6-well tissue culture-treated plate and infected the next day at an MOI of 100 as described 
above (Microscopy-based cell survival assay). After one hour of infection, the cells were 
washed with PBS, and then fixed with 3.7% paraformaldehyde cytoskeleton F buffer59. 
Extracellular bacteria were stained with anti-S. flexneri (Difco Laboratories, 2883-47-3) and 
an Alexa Fluor 488 secondary antibody (Invitrogen, A11034). For experiments assessing E. 
coli pSFT3SS invasion, extracellular bacteria were labeled with rabbit anti-E. coli (Abcam, 
ab137967). The cells were then permeabilized with 0.5% Triton X-100 in cytoskeleton F 
buffer. Actin was stained with Alexa Fluor 568 phalloidin (Invitrogen), and cellular and 
bacterial DNA (both intracellular and extracellular bacteria) were stained with 4,6-
diamidino-2-phenylindole (DAPI; Invitrogen).
Bacterial effector translocation and secretion assays
Fluorescence-based translocation assays were performed as described previously60. In brief, 
S. flexneri strains carrying an IPTG inducible OspB-TEM β-lactamase construct were grown 
to exponential phase at 37°C, and OspB-TEM production was induced with 1 mM IPTG for 
30 min. Y. pseudotuberculosis were grown to exponential phase at 30°C, EGTA was added 
to 10μM, and the cultures were incubated an additional 1.5 hours at 37°C. S. Typhimurium 
carrying an IPTG inducible SopE1-TEM construct was grown to exponential phase at 37°C, 
and IPTG was added for 30 min at 1mM to induce SopE1-TEM production. Vim+/+ and 
Vim−/− MEFs, seeded at 2×104 cells per well in 96-well, flat-bottom, tissue culture-treated 
plates, were pre-loaded with CCF4-AM dye (Invitrogen) according to the manufacturer's 
protocol and infected at an MOI of 200. Bacterial entry was synchronized by centrifugation 
at 800xg for 10 minutes at 25°C. The infection continued for 50 min at 37°C with 5% CO2. 
Images were acquired with a Nikon Eclipse TE-300 inverted microscope using appropriate 
filters. The relative amount of translocation was determined using segmentation tools in 
iVision software (Biovision Technologies).
For quantification of intracellular bacterial effectors by western blot, HeLa cells or Vim+/+ 
and Vim−/− MEFs, seeded at 3×105 cells per well in 6-well tissue culture-treated plates, were 
infected with exponential phase S. flexneri pOspB-FLAG at an MOI of 200, as described 
above (Microscopy-based cell survival assay). After 50 min, the infected cells were lysed 
with RIPA buffer (50mM Tris, pH 8 containing 150mM NaCl, 1% nonidet-P40, 0.1% SDS, 
10mM NaF, and EDTA-free protease inhibitor cocktail [Roche]), which releases soluble 
cytosolic components but does not lyse bacteria. Cellular debris and bacteria were removed 
by centrifugation. OspB-FLAG was detected by western blot using mouse antibody to 
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FLAG (Sigma, F1804). Assessment of bacterial lysis was by western blot using mouse 
antibody to DnaK (Stressgen,SPA-880).
For measurements of T3SS activation using TSAR49, Vim+/+ and Vim−/− MEFs were seeded 
onto coverslips in 6-well plate and infected as described above (Microscopy-based cell 
survival assay). Cells and bacteria were co-cultured for 30 or 60 min. Non-adherent bacteria 
exposed to cells were collected from the infection supernatant and the washes of the cells; 
this fraction was washed once with PBS and fixed with 3.7% paraformaldehyde. Cells and 
associated bacteria were fixed with 3.7% paraformaldehyde, and the DNA was stained with 
DAPI. For measurement of TSAR activation in vimentin complementation experiments, 
after incubation of cells at 25°C for 45 min, the media on the cells was exchanged for warm 
DMEM supplemented with 10% FBS, the cells were incubated for 5 min at 37°C, and 
infections were performed as described above (Microscopy-based cell survival assay). 
Infected monolayers were incubated at 37°C for 60 min, washed once with PBS, and fixed 
with 3.7% paraformaldehyde. Images were acquired with a Nikon Eclipse TE-300 inverted 
microscope using appropriate filters. All bacteria expressed mCherry, and bacteria in which 
T3SS effector secretion was activated expressed GFP49.
Congo red secretion assay
Secretion through the T3SS by bacteria grown in vitro and in the absence of eukaryotic cells 
was induced by the addition to the growth media or to bacteria in phosphate-buffered saline 
of Congo red (to 10 uM), a commonly used activator of S. flexneri T3SS61.
Bacterial binding assays
For assays performed under laminar flow62-65, Vim+/+ and Vim−/− MEFs were seeded at 105 
cells per chamber in a LuerI 0.4μm laminar flow chamber (Ibidi) in DMEM supplemented 
with 10% FBS. Cells were treated with 0.5μg/mL of cytochalasin D, from before infection 
and continuing through the infection. Exponential phase bacteria were stained with Syto-9 
(Invitrogen, S34854) at 37°C for 20 min, washed with DMEM, and applied to cells at an 
MOI of 100. Infection was performed as above (Microscopy-based cell survival assay) and 
allowed to continue for 20 min at 37°C with 5% CO2. The bacteria were subjected to a shear 
force of 0.125 dynes/cm2 for 20 min at 37°C under a flow of DMEM supplemented with 
10% FBS. To quantify bacteria associated with cells, ten random images were collected 
along the midline of the chamber.
Binding studies without laminar flow were performed as previously described14. 30 min 
prior to infection, Vim+/+ and Vim−/− MEFs were treated with cytochalasin D at 0.5 μg/mL 
and cytochalasin D was maintained for the duration of the infection, which followed the 
protocol for “Differential fluorescent microscopy” above and in supplemental methods.
Protein interaction assays
Yeast-based protein interact assays were performed as described previously39, 66, 67. Briefly, 
intermediate filament proteins were tagged with μNS, and the translocon proteins were 
tagged with mCherry (Table S2). Yeast were cultured overnight in the presence of 0.2% 
raffinose, diluted the next morning to OD600 of 0.5, and cultured for 2 hours at 30°C with 
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0.2% raffinose. Then, to induce protein synthesis, the media was changed to 0.2% galactose, 
and growth was allowed to proceed for 6-8 hours at 30°C. mCherry synthesis was monitored 
by fluorescence microscopy. Random images of ~100 yeast were collected for each 
condition in each experiment. Collection of images and analysis of data were performed in a 
blinded manner. Protein interaction was scored based on the presence or absence of 
fluorescent puncta among yeast cells that produced mCherry. Independent experimental 
replicates performed in Fig. 2: (a) Empty-IpaC, n=12; Vimentin-IpaC, n= 15; Empty-
Vimentin, n=3. (b) Empty-IpaC, n=12; Keratin 8-IpaC, n=3; Keratin 18-IpaC, n=15. (c) 
Empty-SipC, n=8; Vimentin-SipC, n=9; Keratin 8-SipC, n=9; Keratin 18-SipC, n=11. (d) 
Empty-YopD, n=11; Vimentin-YopD, n=13; Keratin 8-YopD, n=7; Keratin 18-YopD, n=5. 
(e) Empty-IpaC, n=8; Vimentin-IpaC WT, n=11; Vimentin-IpaC R362E, n=8; Vimentin-
IpaC R362L, n=4; Vimentin-IpaC R362W, n=3; Vimentin-IpaC S349A, n=4. (f) Empty-
IpaC, n=8; Keratin 18-IpaC WT, n=11; Keratin 18-IpaC R362E, n=10; Keratin 18-IpaC 
R362L, n=5; Keratin 18-IpaC R362W, n=3; Keratin 18-IpaC S349A, n=5.
Quantification of translocon proteins in the plasma membrane
Membrane isolation and detection of translocon proteins was performed as described 
previously37. Briefly, Vim+/+ and Vim−/− MEFs, seeded at 6×106 cells per 10cm tissue 
culture-treated dish, were infected with early exponential phase bacteria in 2.5mL of DMEM 
supplemented with 10% FBS at an MOI of 100 for 1 hour at 37°C. For strains carrying an 
arabinose inducible construct, DMEM without glucose was used. The cells were washed 3 
times with ice-cold PBS, scraped off the dish into ice-cold PBS containing protease 
inhibitors, and recovered by centrifugation at 225xg for 5 min at 25°C. The cell pellet was 
cooled on ice for 5 min and was resuspended in ice-cold 50mM Tris, pH 7.5 containing 
protease inhibitors and 0.2% saponin. After incubation on ice for 20 min and centrifugation 
at 16,100xg at 4°C for 30 min, the saponin-solubilized supernatant (cytosolic fraction) was 
collected, and the pellet was resuspended in 50mM Tris, pH 7.5 containing protease 
inhibitors and 1% Triton X-100. After additional incubation on ice for 30 min and 
centrifugation at 16,100xg at 4°C for 15 min, the Triton X-100-soluble supernatant 
(membrane fraction) was collected, and the pellet (detergent insoluble cellular debris and 
intact bacteria) was resuspended in 50mM Tris, pH 7.5 containing protease inhibitors and 
1% Triton X-100. Western blots were performed using mouse anti-DnaK (Stressgen, 
SPA-880), rabbit anti-vimentin (Cell Signaling, 3932S), mouse anti-GAPDH (abcam, 
ab9484), rabbit anti-caveolin-1 (Sigma, C4490), rabbit anti-IpaC (gift from W. Picking), and 
rabbit anti-IpaB (gift of W. Picking).
Pore formation
Pore formation in sheep erythrocyte membranes was performed as previously described7. 
Briefly, 108 erythrocytes were washed with saline and infected with bacteria in stationary 
phase at an MOI of 100 in 30mM Tris, pH7.5. The bacteria were centrifuged onto the 
erythrocytes at 800xg for 10 min at 25°C and cultured at 37°C with 5% CO2 for 50 min. The 
sample was mixed and centrifuged at 800xg for 10 min at 25°C. As a control for lysis, 
erythrocytes alone were resuspended in 0.02% SDS prior to the last centrifugation step. The 
supernatants were transferred to a 96 well plate and OD570 measured using a Wallac 1420 
Victor2 (Perkin Elmer). Pore diameters were estimated with osmoprotectants, as performed 
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previously7, 41. For experiments measuring pore diameter, osmoprotectants were included at 
30mM for the duration of the co-culture.
Pore formation in nucleated cells was performed as described previously41. Cells, seeded in 
96 well flat-bottom plates at 5×104 (bone marrow-derived macrophages) or 1.5×104 (293T 
cells) per well, were preloaded with BCECF, AM [2’-7’-Bis-(2-Carboxyethyl)-5-(and-6)-
Carboxyfluorescein, Acetoxymethyl Ester (Invitrogen, B1170)] and Hoechst (Invitrogen) in 
HBSS at 37°C at 5% CO2. The cells were infected with exponential phase bacteria at an 
MOI of 100 in RPMI; for MEFs, 4% FBS was included. Invasion was synchronized by 
centrifugation at 800xg for 10 min at 25°C, and the infection was continued at 37°C with 5% 
CO2 for indicated times. For assays to measure the translocon pore diameter, 
osmoprotectants of varying sizes were included at 60mM for the duration of the assay. Cells 
were stained with Hoescht (Invitrogen), and fluorescent microscopy was used to image the 
total number of cells (blue filter) and BCECF-positive cells (green filter). To quantify the 
percent of cells that were BCECF-positive, images were analyzed using Cell Profiler (Broad 
Institute).
Cytoskeletal assays
Cells were seeded at 3×105 cells per well on glass coverslips in a 6-well tissue culture-
treated plate and infected the next day at an MOI of 400, as described above (Microscopy-
based cell survival assay). After 30 min, the cells were washed with PBS, and then fixed 
with 3.7% paraformaldehyde and permeabilized with 0.5% Triton X-100, both in 
cytoskeleton F buffer59. Actin was stained with Alexa Fluor 568 phalloidin (Invitrogen, 
A12380), and cellular and bacterial DNA were stained with 4,6-diamidino-2-phenylindole 
(DAPI; Invitrogen). Actin rearrangements were identified by the presence of dense 
concentrations of actin21, 68. To visualize intermediate filaments HeLa cells were infected as 
above except the bacteria were added at an MOI of 100 and the infection carried out for 1 
hour. Intermediate filaments were stained with rabbit anti-keratin 18 (abcam, 133263), rabbit 
anti-keratin 8 (Abcam, 53280), mouse anti-vimentin (Sigma, V6630, V-9 clone), goat anti-
rabbit Alexa Fluor 488 (Invitrogen, A11034), and goat anti-mouse Alexafluor 488 
(Invitrogen, A1101). Bacteria were visualized with DAPI.
Microscope and data analysis
Epifluorescence and phase-contrast microscopy were performed using a Nikon Eclipse 
TE300 or Nikon TE-2000-S microscope equipped with Chroma Technology filters and a 
Photometrics CoolSNAP HQ charge-coupled device camera (Roper Scientific) or a Q-
Imaging Exi Blue camera (Q-Imaging). Images were acquired using iVision software 
(BioVision Technologies). Unless otherwise noted, for all other experiments involving 
microscopy, images were collected in a random manner across the coverslips. Color figures 
were assembled and digitally pseudocolored using Adobe Photoshop software.
For densitometry analysis of western blots, the chemoilluminescent signal was detected 
using film, films were scanned with an Epson Perfection 4990 Photo scanner, and band 
intensity was determined using ImageJ (NIH).
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Unless otherwise indicated, for all experiments, a minimum of three independent 
experiments were conducted on independent days, using independent cultures, and where 
appropriate, independent plating of cells.
Statistical Analysis
All statistical analysis was performed using Graphpad Prism 6 (Graphpad Software). For 
experiments containing two groups, statistical significance was determined using a Student's 
t-test. Unless otherwise stated, for experiments containing three or more groups, statistical 
significance was determined using a one-way ANOVA followed by a Dunnett's post hoc test 
or a two-way ANOVA followed by a Sidak post hoc test. Experimental conditions were 
performed once per experiment, unless otherwise noted. Amino acid similarity among 
proteins was determined using clustalΩ69.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Efficient T3SS translocation depends on intermediate filaments
(a) Cell viability of MEFs following infection with S. flexneri for 24 h. Viability determined 
by trypan staining and counting of recovered cells. Vim−/−:huVim, human vimentin 
expressed in Vim−/− MEFs. Data are mean ± SEM of three independent experiments for 
each group. *, P<0.05; one-way ANOVA with Tukey post hoc test. (b) Levels of vimentin in 
cells used for experiments in panel a, by western blot. Images shown are from one 
experiment, representative of three independent experiments. (c-f) Assessment of 
translocation efficiency by conversion of CCF4-AM fluorescence emission from green to 
blue upon infection of MEFs with bacteria that translocate a bacterial type 3 effector-β-
lactamase reporter. (c) Images of fluorescence emission for S. flexneri expressing OspB-
TEM. Images presented are representative of seven independent experiments. Scale bar, 100 
μm. (d-f) Quantification of fluorescent images: (d) S. flexneri expressing OspB-TEM, mean 
± SEM of seven independent experiments. (e) S. Typhimurium expressing SopE1-TEM, 
mean ± SEM of five independent experiments for media and WT and four independent 
experiments for ΔinvG. (f) Y. pseudotuberculosis expressing YopE-TEM, mean ± SEM of 
three independent experiments. Effector translocation was dependent on a functional T3SS 
apparatus, irrespective of the presence or absence of vimentin, as shown by Δspa15, ΔinvG, 
and ΔyopD mutants, which are deficient in T3SS activity.. ***, P<0.001; two-way ANOVA 
followed by Sidak post hoc test.
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Figure 2. The S. flexneri T3SS translocon pore protein IpaC and its homologs in other pathogens 
interact with intermediate filaments and this interaction is required for efficient translocation.
(a-f) Yeast based protein-protein interaction assay. The number of experimental replicates 
for each condition is included in Methods “Protein interaction assay”. *, P<0.05, **, P<0.01, 
***, P<0.001; one-way ANOVA with Dunnett's post hoc test. (g) Infection of Vim+/+ MEFs 
with S. flexneri strains expressing OspB-TEM reporter to assess translocation efficiency by 
conversion of CCF4-AM fluorescence emission from green to blue upon type 3 
translocation. The data are the mean ± SEM of three independent experiments. ***, 
P<0.001, one-way ANOVA with Dunnett's post hoc test.
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Figure 3. Intermediate filaments are dispensable for translocon pore formation
(a) Analysis of IpaC and IpaB incorporation in the plasma membrane using detergent 
fractionation of Vim+/+ and Vim−/− MEFs infected with S. flexneri. All panels are from the 
same experiment and are representative of three independent experiments. (b) Kinetics of 
translocon pore formation measured by BCECF dye release from Vim+/+ and Vim−/− bone 
marrow-derived macrophages infected with E. coli pSfT3SS at a sub-maximal multiplicity 
of infection. Data are the mean ± SD of one experiment, representative of three independent 
experiments. Independent wells were used for each experimental time point shown, media 
treatment was performed once, and infection with E. coli pSfT3SS was performed in 
triplicate wells. (c) BCECF release from Vim+/+ and Vim−/− bone marrow-derived 
macrophages infected with E. coli pSfT3SS as a function of the multiplicity of infection. 
The data presented are mean ± SD of one experiment performed in duplicate wells and are 
representative of three independent experiments. (d) Estimation of translocon pore diameter 
based on inhibition of BCECF dye release by osmoprotectants of varying diameters. E. coli 
pSfT3SS infection of Vim+/+ and Vim−/− bone marrow-derived macrophages. The data 
presented are mean ± SD of one experiment performed in duplicate wells and are 
representative of three independent experiments.
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Figure 4. E. coli pSfT3SS reproduces S. flexneri phenotypes
(a) Translocation of OspB-FLAG by E. coli pSfT3SS into the cytosol of Vim+/+ and Vim−/− 
MEFs. Western blot for FLAG, DnaK, a cytosolic bacterial protein, and actin. The two 
DnaK panels are from the same exposure of the same western blot, and all panels are from 
the same experiment, which is representative of three independent experiments. Within each 
experiment, translocation by E. coli pSfT3SS was assessed in triplicate. (b) Conversion of 
CCF4-AM fluorescence emission from green to blue upon translocation of the OspBTEM 
reporter by WT S. flexneri or E. coli pSfT3SS into Vim+/+ and Vim−/− MEFs. Data are the 
mean ± SEM of three independent experiments. **, P<0.01; two-way ANOVA with Sidak 
post hoc test. (c) Infection of Vim+/+ and Vim−/− MEFs by E. coli pSfT3SS, quantified by 
differential staining microscopy. Data are the mean ± SEM of three independent 
experiments. *, P<0.05; Student's t-test. (d) Pore size, as determined by the impact of 
osmoprotectants on lysis of erythrocytes by S. flexneri or E. coli pSfT3SS. Data are 
representative of two independent experiments. (e) Quantification of data from experiments 
depicted in panel d. Lysis is normalized to media alone in the presence of S. flexneri or E. 
coli pSfT3SS. Data are the mean ± SEM and of two independent experiments, each 
performed in triplicate. Means not significantly different by Student's t-test.
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Figure 5. The interaction of intermediate filaments with the translocon pore is required for 
efficient docking of S. flexneri
Bacterial docking to Vim+/+ and Vim−/− MEFs following a laminar flow of 0.125 dynes/cm2. 
(a) Representative images of S. flexneri-infected Vim+/+ and Vim−/− MEFs after 
centrifugation onto cells followed by exposure to laminar flow. Scale bar, 20 μm. Arrows, 
docked bacteria. Arrowheads, bacteria that were not docked, as indicated by their being 
outside the focal plane. (b) Quantification of docking of WT bacteria to Vim+/+ versus 
Vim−/− MEFs, as indicated. Data are the mean ± SEM of six independent experiments for 
WT infection of Vim+/+, five independent experiments for WT infection of Vim−/−, four 
independent experiments for ΔipaC infection of Vim+/+, and three independent experiments 
for ΔipaC infection of Vim−/−. *, P<0.05; two-way ANOVA with a Sidak post hoc test. (c) 
Quantification of docking of bacteria expressing WT or mutant IpaC to Vim+/+ MEFs. Data 
are the mean ± SEM of four independent experiments. *, P<0.05; Student's t-test.
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Figure 6. Activation of effector secretion requires S. flexneri docking
(a) Images of docked WT bacteria at 30 min of infection. Bacteria activated to secrete 
effectors through T3SS express GFP (TSAR, green), all bacteria express mCherry (red), 
DNA labeled with DAPI (blue). Arrows, TSAR positive bacteria. Scale bar, 10 μm. Images 
are representative of three independent experiments. (b-c) Quantification of cell-associated 
bacteria that have activated TSAR at 30 min or 60 min of infection. *P<0.05; Student's t-
test. Data are the mean ± SEM of at least three independent experiments. (d) Absence of 
TSAR expression among bacteria centrifuged onto cells yet non-adherent at 30 min of 
infection. Images are representative of three independent experiments. Scale bar, 10 μm. (e) 
Quantification of data presented in d. Data are the mean ± SEM of three independent 
experiments. (f) Rescue of docking of bacteria by genetic complementation of Vim−/− MEFs 
with human vimentin. Vim−/−:huVim, human vimentin expressed in Vim−/− MEFs. Data are 
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the mean ± SEM of three independent experiments. *P<0.05, **P<0.01; one-way ANOVA 
with Tukey post hoc test.
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